Clifford Kashtan, MD and Michelle Rheault, MD give us the inside scoop on Alport Syndrome- when to consider the diagnosis, the role of a biopsy and genetic testing, benefits of early treatment and surveillance and management strategies.

Dr. Kashtan is a tenured Professor of Pediatrics at the University of Minnesota and an international expert in Alport Syndrome. He founded, and is still the director, of the Alport Syndrome Treatments and Outcomes (ASTOR) registry and is on the board of the Alport Syndrome Foundation. He has authored countless textbook chapters, articles and clinical research on the topic.

Dr. Rheault is an Associate Professor of Pediatrics and division chief of pediatric nephrology at the University of Minnesota. She has a special interest in Alport Syndrome, nephrotic syndrome and genetic diseases. She serves the board of Women in Nephrology as well as the Pediatric Nephrology Research Consortium. She is an active clinical researcher and “Tweet-iatrician.”

Please reach out with comments/suggestions/feedback! [email protected]